In addition, PA treatment induces the production of pro-inflammatory chemokine IL-8 in HepG2 cells, recapitulating the elevated IL-8 levels seen in NASH patients [73,89,90]. The gene discussed is CXCL8; the disease is metabolic dysfunction-associated steatohepatitis.